Autopsy report · NCT03661983
Trial to Evaluate the Long-term Efficacy of Oral Aripiprazole in the Treatment of Pediatric Participants With Tourette's Disorder
Cause of deathOther
“Lack of feasibility for completion of the trial within a reasonable time frame.”
Life of this trial
- Registered 1 month before it started.
- Ran for about 1 year 9 months before it stopped.
- 36 participants enrolled.
- Results were posted on the registry 7 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Sponsor type
- Industry
- Conditions
- Tourette's Disorder (TD)
- Interventions
- Aripiprazole; Placebo
- Participants
- 36
- Sites
- 42
- Countries
- Canada, Hungary, United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.